共 129 条
[1]
Fisher B(1998)Effect of prospective chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672-2685
[2]
Bryant J(2001)Cooperating investigators: Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902 J Clin Oncol 19 4224-4237
[3]
Wolmark N(1999)Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorabicine-based neoadjuvant chemotherapy J Clin Oncol 17 460-469
[4]
Mamounas E(1994)Neoadjuvant versus adjuvant chemotherapy in premonopausal patients with tumours considered too large for breast conserving surgery preliminary results of a randomized trial: S6 Eur J Cancer 30 645-652
[5]
Brown Ann(1999)Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow up. Institut Bergoni Bordeaux Groupe Sein (IBBGS) Ann Oncol 10 47-52
[6]
Fisher ER(1999)Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimilating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study J Clin Oncol 17 460-469
[7]
Wicerham DL(1996)A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent cancer British J Cancer 73 210-216
[8]
Begovic M(2002)Aberdeen Breast Group: Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial Clin Breast Cancer 2 69-74
[9]
DeCillis A(2003)National Surgical Adjuvant Breast and Bowel Project B-27: The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 21 4165-4174
[10]
Robidoux A(2001)Histopathological Criteria for Assessment of Therapeutic Response in Breast Cancer Breast Cancer 8 1-2